Matt Lanktree | #NephroGenetics

Clinician Scientist in Nephrology Genetics @McMasterU @StJoesHamilton @PHRIresearch

[Matt Lanktree | #NephroGenetics @MattLanktree]

@s_almutar See you there! Looks like a great case!

[Matt Lanktree | #NephroGenetics @MattLanktree]

@NWiegley @NKF_NephPros @NKFNorthernCA @nkf Great to meet you! Excellent session!!

[Nasim Wiegley, MD, FASN @NWiegley]

Kicked off #NKFSCM 2026 with the #Nephrogenetics workshop — great to be on the panel alongside Drs. Alex Chang, @MattLanktree, & Christie Thomas. Important conversations happening at the intersection of genetics and kidney disease. 🧬

[Matt Lanktree | #NephroGenetics @MattLanktree]

@ISNkidneycare @kidney_boy Congratulations Jai! In great hands!

[Int Society of Nephrology @ISNkidneycare]

@KIReports ➡️ Moving Mendelian Randomization From Traditional Risk Factors to Molecular Targets for Drug Development and Clinical Trials in Nephrology https://t.co/sddKvI2Am9

[Matt Lanktree | #NephroGenetics @MattLanktree]

How can genomics and Mendelian randomization help drug targets traverse the "Valley of Death" in kidney research?
Please see and share our new paper:
https://t.co/r132NDUaUe

[ASN Publications @asnpublications]

This prospective study in #ASNJASN of 976 adults measured the association between subclinical primary aldosteronism and kidney outcomes. Read more: https://t.co/7d7isydJVr

[Abed Borghol @abedborghol]

Kidney stones in ADPKD are common yet often overlooked, with rates from 3-59%.
Check out our recent article on kidney stones in ADPKD, with a focus on how metabolic and structural factors impair drainage and complicate management🫘💎.
@fouadchebib
https://t.co/5ZdbQO15tH

[Matt Lanktree | #NephroGenetics @MattLanktree]

What an awesome session on common variant CKD genetics @ASNKidney #KidneyWk @kidneyomicsamps @LoebLab @LimdiNita

[Matt Lanktree | #NephroGenetics @MattLanktree]

@drjohnm @AndrewFoy82 ESKD and HF patients die of other causes due to competing risks… but those at highest risk of atherosclerotic events still would have the most to benefit from statin.

[Matt Lanktree | #NephroGenetics @MattLanktree]

@KidneyMajeed @kidneyomicsamps Look at that furrowed brow! Deep in thought!

[Majeed Alsadhan @KidneyMajeed]

Fantastic session on genetic studies of complex kidney traits and diseases using large scale biobanks and multi-omic approaches, moderated by @MattLanktree and @kidneyomicsamps (double the Matts, double the insight!) #KidneyWk

[Matt Lanktree | #NephroGenetics @MattLanktree]

@KidneyMajeed Congratulations!! So proud to continue our collaboration!!

[Majeed Alsadhan @KidneyMajeed]

🧬🫘Excited to share that our team presented 3 posters at #KidneyWk
Genetic kidney disease is an evolving and rapidly expanding field, and we’re proud to contribute through both patient care and research.
Grateful for the opportunity to share, connect, and learn. Until next year!

[Kidney Foundation @kidneycanada]

We are celebrating 25 years of partnership impact with @CIHR_IRSC! Together we’ve trained researchers, advanced equitable care, and improved the health of Canadians living with kidney disease. Learn more: https://t.co/dIln682ssH #KidneyResearch #HealthInnovation #CIHR25

[Benoît Brilland @BenoitBrilland]

A 4-protein plasma index (UMOD, MIOX, HPSE, AREL1) detects early kidney damage in DKD & #lupus #nephritis better than eGFR or albuminuria (AUC = 0.92–1.00 vs 0.27–0.94). M. Nerenberg #KidneyWk TH-OR042

[Matt Lanktree | #NephroGenetics @MattLanktree]

@AJKDonline I’m surprised they don’t include HNF1B nephropathy in the ADTKD umbrella. While variable, at times it can present more similar to ADTKD-UMOD than ADTKD-REN!

[Matt Lanktree | #NephroGenetics @MattLanktree]

“Educating the next generation expert in nephrology genetics”: we need a new workforce to deal with rapidly growing role of genetics in Nephrology!

https://t.co/9h98ECHl0u

[Matt Lanktree | #NephroGenetics @MattLanktree]

@QMyPath @TheKingLab @CellStemCell @marcobuttigieg_ @DrFlashHeart @QueensUHealth @tmedQueens @QueensMDPhD @SSHRC_CRSH @CIHR_IRSC Congratulations on the progress!
And what a shout out!

[ASN Publications @asnpublications]

Study finds that Non-DNMT3A CHIP was associated with CKD progression among individuals with CKD, and Tet2-CHIP mouse models support a causal role in kidney injury. https://t.co/rWgyrsGFHg
#ASNJASN